Randy A. Brown

1.8k total citations
39 papers, 1.1k citations indexed

About

Randy A. Brown is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Randy A. Brown has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Randy A. Brown's work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Neutropenia and Cancer Infections (6 papers). Randy A. Brown is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Neutropenia and Cancer Infections (6 papers). Randy A. Brown collaborates with scholars based in United States, Japan and Canada. Randy A. Brown's co-authors include John F. DiPersio, H. Jean Khoury, Douglas R. Adkins, Debra Frei‐Lahr, Ravi Vij, David D. Hurd, Timothy J. Ley, Margaret Kindlen, Selina M. Luger and Peter Westervelt and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Randy A. Brown

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randy A. Brown United States	17	531	384	322	187	126	39	1.1k
Kensuke Naito Japan	18	623 1.2×	308 0.8×	660 2.0×	130 0.7×	142 1.1×	51	1.2k
Noriyoshi Iriyama Japan	18	429 0.8×	265 0.7×	313 1.0×	98 0.5×	293 2.3×	83	948
Kazuyuki Shigeno Japan	15	296 0.6×	238 0.6×	364 1.1×	45 0.2×	70 0.6×	36	644
Nicholas Wickham Australia	16	292 0.5×	130 0.3×	256 0.8×	86 0.5×	174 1.4×	35	804
Jean Paul Fermand France	17	603 1.1×	357 0.9×	1.5k 4.8×	159 0.9×	433 3.4×	36	1.9k
Thomas A Ratko United States	16	255 0.5×	143 0.4×	172 0.5×	104 0.6×	28 0.2×	32	813
Giuseppe Papa Italy	18	310 0.6×	137 0.4×	186 0.6×	138 0.7×	128 1.0×	36	1.1k
Alexandra M. Harrington United States	17	227 0.4×	361 0.9×	398 1.2×	126 0.7×	149 1.2×	64	1.0k
Zalmen A. Arlin United States	19	577 1.1×	336 0.9×	303 0.9×	75 0.4×	227 1.8×	53	1.1k
Beth A. Bouchard United States	17	714 1.3×	183 0.5×	229 0.7×	152 0.8×	209 1.7×	36	1.4k

Countries citing papers authored by Randy A. Brown

Since Specialization

Citations

This map shows the geographic impact of Randy A. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy A. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy A. Brown more than expected).

Fields of papers citing papers by Randy A. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy A. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy A. Brown. The network helps show where Randy A. Brown may publish in the future.

Co-authorship network of co-authors of Randy A. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Randy A. Brown. A scholar is included among the top collaborators of Randy A. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy A. Brown. Randy A. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wingard, John R., Ji‐Hyun Lee, Zeina Al‐Mansour, et al.. (2025). Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia. Journal of Clinical Oncology. 44(4). 300–310.

Noureddin, Mazen, Stephen A. Harrison, Rohit Loomba, et al.. (2025). Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study. The Lancet. 406(10520). 2644–2655. 2 indexed citations

Douglas, Elliot P., et al.. (2024). Engineering Firms as Racialized Organizations: The Experiences of Black Male Engineers. Papers on Engineering Education Repository (American Society for Engineering Education).

Cline, Christina, Zeina Al‐Mansour, Ji‐Hyun Lee, et al.. (2024). A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia. Leukemia & lymphoma. 65(10). 1502–1510.

Harrison, Stephen A., Shaheen Tomah, John J. Suschak, et al.. (2023). Pemvidutide, a glp-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and body weight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial. Journal of Hepatology. 78. S54–S55. 4 indexed citations

Dean, Erin, et al.. (2022). Viral Clearance with Neutrophil Recovery in a Patient with Active COVID-19 Infection and Refractory Acute Myeloid Leukemia Who Underwent Successful Reinduction with Cytarabine/Idarubicin. SHILAP Revista de lepidopterología. 15(2). 705–712. 2 indexed citations

Farhadfar, Nosha, Debra Lynch Kelly, Shalini Nair, et al.. (2020). Dietary Intake and Diet Quality of Hematopoietic Stem Cell Transplantation Survivors. Biology of Blood and Marrow Transplantation. 26(6). 1154–1159. 16 indexed citations

Drusbosky, Leylah, Kimberly E. Hawkins, Glenda G. Anderson, et al.. (2018). iCare 1: A prospective clinical trial to predict treatment response based on genomics-informed computational biology in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 36(15_suppl). 7024–7024.

Lutfi, Forat, William Paul Skelton, Nosha Farhadfar, et al.. (2017). Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center. Blood. 130. 4529–4529. 2 indexed citations

10.

Norkin, Maxim, Myron Chang, Yunfeng Dai, et al.. (2017). Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia. Blood Cancer Journal. 7(12). 634–634. 20 indexed citations

11.

Norkin, Maxim, Myron Chang, Qi An, et al.. (2016). A new model to predict remission status in AML patients based on day 14 bone marrow biopsy. Leukemia Research. 46. 69–73. 13 indexed citations

12.

Turner, Daniel J., Robert Hromas, John R. Wingard, et al.. (2015). Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome. Leukemia Research Reports. 4(1). 24–27. 13 indexed citations

13.

Hallemeier, Christopher L., Mark D. Girgis, William Blum, et al.. (2006). Long-Term Remissions in Patients with Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia Undergoing Allogeneic Transplantation Following a Reduced Intensity Conditioning Regimen of 550 cGy Total Body Irradiation and Cyclophosphamide. Biology of Blood and Marrow Transplantation. 12(7). 749–757. 22 indexed citations

14.

Giles, Francis J., Paula M. Fracasso, Hagop M. Kantarjian, et al.. (2003). Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leukemia Research. 27(12). 1077–1083. 79 indexed citations

15.

Devine, Steven M., Douglas R. Adkins, H. Jean Khoury, et al.. (2003). Recent advances in allogeneic hematopoietic stem-cell transplantation. Journal of Laboratory and Clinical Medicine. 141(1). 7–32. 22 indexed citations

16.

Vij, Ravi, Douglas R. Adkins, William Blum, et al.. (2003). Long‐term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor‐induced neurotoxicity. British Journal of Haematology. 123(1). 110–113. 20 indexed citations

17.

Bodó, Imre, Marion G. Peters, Jerald P. Radich, et al.. (1999). Donor-Derived Acute Promyelocytic Leukemia in a Liver-Transplant Recipient. New England Journal of Medicine. 341(11). 807–813. 44 indexed citations

18.

Brown, Randy A., Joseph W. Fay, Luis Piñeiro, et al.. (1996). High-Dose Etoposide, Cyclophosphamide and Total Body Irradiation with Allogeneic Bone Marrow Transplantation for Resistant Acute Myeloid Leukemia: A Study by the North American Marrow Transplant Group. Leukemia & lymphoma. 22(3-4). 271–277. 22 indexed citations

19.

Frei‐Lahr, Debra, et al.. (1991). Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. Journal of Clinical Apheresis. 6(1). 16–20. 48 indexed citations

20.

Ratner, Lee, Nancy Vander Heyden, Elizabeth Paine, et al.. (1990). Familial adult T‐cell leukemia/lymphoma. American Journal of Hematology. 34(3). 215–222. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact